Loading clinical trials...
Loading clinical trials...
Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome
Conditions
Interventions
IncobotulinumtoxinA 100 UNT Injection [Xeomin]
OnabotulinumtoxinA 100 UNT [Botox]
Locations
1
Italy
Antonella Giannantoni
Siena, SI, Italy
Start Date
September 1, 2018
Primary Completion Date
September 1, 2021
Completion Date
September 1, 2021
Last Updated
November 6, 2020
NCT04873037
NCT06198439
NCT06769854
NCT03535857
NCT06616675
NCT05719285
Lead Sponsor
University Of Perugia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions